FETALPROJECT2010

Documentation of lung growth after tracheal occlusion to reverse pulmonary hypoplasia in congenital diaphragmatic hernia. Experimental studies in the rat and clinical implications of fetal therapy

 Coordinatore EBERHARD KARLS UNIVERSITAET TUEBINGEN 

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Dr.
Nome: Harald
Cognome: Abele
Email: send email
Telefono: 4970710000000
Fax: 497071000000

 Nazionalità Coordinatore Germany [DE]
 Totale costo 45˙000 €
 EC contributo 45˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2010-RG
 Funding Scheme MC-ERG
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-11-01   -   2013-10-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN

 Organization address address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074

contact info
Titolo: Dr.
Nome: Harald
Cognome: Abele
Email: send email
Telefono: 4970710000000
Fax: 497071000000

DE (TUEBINGEN) coordinator 45˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

surgery    lung    mrs    fetuses    rat    distinct    fluid    invasive    nf    asm    occlusion    impact    offer    nifedipine    fetal    fmeg    cdh    host    pulmonary   

 Obiettivo del progetto (Objective)

'The objective of the “Fetalproject2010” is to advance our knowledge in fetal medicine. We focus on pulmonary hypoplasia (PH) in congenital diaphragmatic hernia (CDH) and its relatively new prenatal treatment option, tracheal occlusion (TO). TO prevents egress of pulmonary fluid, thus triggering lung growth. Yet, the procedure is invasive, with main risks premature rupture of membranes and preterm delivery. The question remains as to the optimal occlusion period. We aim to investigate the effects of TO at distinct phases of lung development in the nitrofen (NF) rat. Our results will provide a scientific basis for timing of TO in human CDH fetuses. Patients after fetal surgery are at high risk for tocolysis. One drug frequently used is nifedipine, which inhibits airway small muscle (ASM) contractions in vitro. ASM are believed to be crucial for lung development. We plan to study the impact of nifedipine application on hypoplastic lungs ±TO in the NF rat. Our results will demonstrate potential safety issues. Few centers, including the two host institutions, offer fetal surgery such as TO. We aim to investigate with questionnaires how couples are affected psychologically by interventions. Our results will help to identify the distinct needs of these parents and to tailor support. MRI-spectroscopy (MRS) and fetal magnetoencephalography (fMEG) offer new non-invasive methods to study fetal fluid composition, organ function and development. CDH is associated with altered levels of e. g. vitamin A and decreased cerebral perfusion, the functional impact of the latter is unknown. We aim to investigate the potential of MRS and fMEG in studying lung development as well as brain activity in fetuses with CDH. These results will help to define new markers and methods for diagnostic and prognostic purposes in fetuses with CDH. This grant will help to reintegrate an experienced researcher coming from KU Leuven, Belgium, into the new host organization, University Tübingen, Germany.'

Altri progetti dello stesso programma (FP7-PEOPLE)

RESEARCH FUN (2010)

Research Fun for Society

Read More  

UNFITHIV (2012)

Understanding the importance of viral Fitness Impairment after Transmission of HIV: Implication on HIV vaccine design

Read More  

T CELL HOMEOSTASIS (2010)

Conditioning regimens shape the homeostasis of adoptively transferred T cells: Effects on autoreactivity and role in anti-tumor therapy

Read More